MRPath Incorporated
MRPath was cofounded by Drs. Robert Lontz and G. Allan Johnson. The MRPath president, Dr. Lontz previously served as Chief Executive Officer of Magnetic Imaging Technologies Incorporated. Dr. G. Allan Johnson is the Professor of Radiology and Physics and Director of the Center for In Vivo Microscopy at the Duke University Medical Center.
Much of the technology of MRPath is inspired by magnetic resonance (MR) techniques developed under National Institutes of Health research awards. These include a grant from the National Cancer Institute to develop a reference of high resolution mouse MRI (The Visible Mouse); and applications of MR imaging for rodent teratology, neurotoxicology, and In Vivo studies for the National Institute of Environmental Health Sciences.
The MRPath founders were initially motivated by a desire to make available a heretofore expensive and specialized imaging capability to a broad community of users in research and industry. In addition to special expertise in MR microscopy, the company offers other imaging modalities, the management of image intense databases, and their integration within protocols and studies. This experience led to the creation of a software product line, which addresses many of the problems in scientific image management.
MRPath is the second biotechnology startup for Drs. Johnson and Lontz. They were the original founders of Magnetic Imaging Technologies, Incorporated (MITI). This company was started in 1996 to develop clinical pulmonary MRI applications of hyperpolarized gas. MITI was acquired three years later by a pharmaceutical firm.
Our interest is in developing interactions, whereby MRPath services and products enable its customers to increase their revenues, achieve cost savings, or enhance their asset value. We look forward to interactions with virtually any users of scientific and technical imaging. In addition to the scientific community, these include users within the biotechnology, pharmaceutical, and chemical sectors.